Histamine intolerance and Mast Cell Activation Syndrome (MCAS) are two distinct conditions with different underlying mechanisms, different diagnostic criteria, and different clinical presentations though they share enough surface-level overlap in symptoms that they are frequently confused, misdiagnosed, or conflated by patients and even some clinicians
They need to think about the health implications of what they are doing and the long-term damage." Dispensing assistant Mary Roach, 58, of Watersheddings, Oldham, said she uses sunbeds for health reasons
Weight loss is not one-size-fits-all, and neither is supplementation
Retatrutide has been associated with reductions in triglycerides in trial data, whereas elevated GH levels from tesamorelin can alter fatty acid mobilisation
There have been fewer than 200 cases of PNST reported since it was first described in 1932 (10,11), with approximately 40 reported malignancies as of 2014 (12)
Microdosing GLP-1 uses the smallest measurements on your syringe